-
My Account
In App
My Account
As on 31 Oct, 2025 | 11:56
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 814014 | 1.52 | 1.53 | 149179 |
| 1090000 | 1.51 | 1.54 | 813038 |
| 1043924 | 1.50 | 1.55 | 92287 |
| 1129848 | 1.49 | 1.56 | 182000 |
| 1066952 | 1.48 | 1.57 | 198700 |
| 9934658 | Total | Total | 7853585 |
| Open | 0.00 |
| Previous Close | 0.00 |
| Volume | 0.00 |
| Value (Lacs) | 0.00 |
| VWAP | 0.00 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 0 |
| High | 0.00 |
| Low | 0.00 |
| UC Limit | 0.00 |
| LC Limit | 0.00 |
| 52 Week High | 0.00 |
| 52 Week Low | 0.00 |
| Face Value | 0.00 |
| All Time High | 0.00 |
| All Time Low | 0.00 |
| 20D Avg Volume | 0 |
| 20D Avg Delivery(%) | -- |
| Book Value Per Share | -- |
| Dividend Yield | -- |
| TTM EPS See historical trend | 0.00 |
| TTM PE See historical trend | -- |
| P/B See historical trend | -- |
| Sector PE | 0.00 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
4 out of 7 years Remedium Lifecare has given negative returns in October.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| October | 4.08% | 2.17% | -33.07% (2024) | -19.75% | -10.36% |
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y Jun 24 2025 11:11 AM
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y Nov 26 2024 10:19 AM
Remedium Lifeca Standalone June 2024 Net Sales at Rs 77.70 crore, down 76.49% Y-o-Y Aug 19 2024 09:29 AM
Remedium Lifeca Standalone March 2024 Net Sales at Rs 1,408.49 crore, up 1763.59% Y-o-Y May 28 2024 12:47 PM
Be patient. Markets are in turmoil. Price should be over Rs 5 in short term View more
Posted by : Billionaireinmaking
plz tell ye share upside move karega ya nhi.....dec.25target price kya rhega View more
Posted by : priyalok
Posted by : The Fixed Income
Repost this message
Build Steady Wealth with a Secured NBFC Bond Investment VIVRITI CAPITAL LIMITED 2027 ✔️ Coupon: 9.15% ✔️ Rating: CARE A+ Stable ✔️ Tenor: 2y (Maturity: 04/Nov/2027) Senior Secured Bond | NBFC Bond | High Return Bond | Listed This bond offers investors the opportunity to earn steady returns while maintaining a conservative risk profile. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJhbmJ3PT0=/915-vivriti-capital-limited-2027?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 6897226 | Price 1.5 | % Traded 0.76 |
| Qty 5356362 | Price 1.5 | % Traded 0.59 |
| Qty 4134084 | Price 1.6 | % Traded 0.49 |
| Qty 356362 | Price 1.67 | % Traded 0.04 |
| Qty 5750000 | Price 1.46 | % Traded 0.61 |
| Qty 5000000 | Price 1.44 | % Traded 0.53 |
| Qty 3000000 | Price 1.48 | % Traded 0.32 |
| Qty 5128137 | Price 1.47 | % Traded 0.57 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Remedium Lifeca | 1.52 | 1.33 | 136.06 | - | 1.43 | 3.53 | -63.55 | 1 | 222 | 26.36 |
| Adani Enterpris | 2,500.80 | -1.03 | 288,637.52 | 45.25 | 6.89 | 14.88 | -15.15 | 7,510 | 97,894 | 1.60 |
| Sundram | 963.35 | 0.31 | 20,242.72 | 36.53 | 5.31 | 14.14 | -27.66 | 541 | 5,955 | 0.21 |
| Redington | 254.75 | -1.49 | 19,915.70 | 12.19 | 2.62 | 18.40 | 31.00 | 1,820 | 99,333 | 0.30 |
| MMTC | 68.74 | -1.26 | 10,311.00 | 105.75 | 5.99 | 5.08 | -12.77 | 69 | 2 | 0.00 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
